Chemomab Therapeutics Ltd. Research And Development Expense
Chemomab Therapeutics Ltd. (CMMB) reported Research And Development Expense of $7.56 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2019-04-24
| Period end | Research And Development Expense 12 month |
|---|---|
| 2018-12-31 | $7.56M 20-F · filed 2019-04-24 |
| 2017-12-31 | $6.23M 20-F · filed 2019-04-24 |
| 2016-12-31 | $2.38M 20-F · filed 2019-04-24 |